Diversify Your Engager Pipeline Beyond Oncology

Accelerate the Development of T-Cell Engagers in Autoimmune Indications Through Reducing CRS Toxicities, Improving Tissue Targeted Depletion & Expanding Targets Beyond B Cells

As breakthroughs in CAR-T cell therapies reshaped the autoimmune landscape, attention was shifting toward the enormous potential of T-cell engagers (TCEs) to deliver safer, more scalable, and physician-friendly treatments in 2025. With innovations in CD3 affinity tuning, selective B-cell depletion, CRS mitigation, and novel autoimmune target discovery, TCEs were perfectly positioned to revolutionize immunology beyond oncology.

The T-Cell Engager for Autoimmune Disease Summit was the first and only hyper-focused industry event dedicated exclusively to accelerating TCE development for autoimmune and inflammatory disorders. This three-day forum united leading immunology researchers, biotech pioneers, and pharma executives to tackle the most pressing challenges in engineering, safety, and clinical translation.

I enjoyed the organization of the conference: there were many high quality and relevant speakers. I also appreciated the conference size and structure, which facilitated networking and allowed for plenty of audience participation.

Rondo Therapeutics

Rondo Therapeutics

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse tellus eros, eleifend eu dolor sed, vulputate sodales risus. Donec non odio vitae sapien tempor aliquet at tincidunt libero.

First Name, Job Title, Company Name

Placeholder Logo

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse tellus eros, eleifend eu dolor sed, vulputate sodales risus. Donec non odio vitae sapien tempor aliquet at tincidunt libero.

First Name, Job Title, Company Name

Placeholder Logo

Explore the Full Event Guide

  • Discover how developers are translating lessons from oncology and CAR-T into smarter, more scalable TCE formats
  • Discover cutting-edge approaches to optimize therapeutic selectivity, potency, and tolerability in autoimmune settings
  • Learn how preclinical models and translational strategies can build regulatory confidence
  • Benchmark your programs against real-world clinical insights
  • Hear from academic superstars
Copy of Brochure Portrait Cover TEMPLATE 1400 x 900 (9)

Official Partners

Attending Companies Include

Explore the Agenda - About Event - T-Cell Engager for Autoimmune Disease Summit

Explore the Agenda

Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.

Partner with us - T-Cell Engager for Autoimmune Disease Summit

Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

Join Biopharma Experts - T-Cell Engager for Autoimmune Disease Summit

Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.